{"id":"NCT01392326","sponsor":"Novartis Pharmaceuticals","briefTitle":"Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA)","officialTitle":"A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Secukinumab to Demonstrate the Efficacy at 24 Weeks and to Assess the Long Term Safety, Tolerability and Efficacy up to 2 Years in Patients With Active Psoriatic Arthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-09","primaryCompletion":"2014-10","completion":"2014-10","firstPosted":"2011-07-12","resultsPosted":"2016-02-04","lastUpdate":"2016-02-04"},"enrollment":606,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Psoriatic Arthritis"],"interventions":[{"type":"DRUG","name":"Secukinumab (75 mg)","otherNames":[]},{"type":"DRUG","name":"Secukinumab (150 mg)","otherNames":[]},{"type":"DRUG","name":"Placebo Comparator","otherNames":[]}],"arms":[{"label":"Group 1","type":"EXPERIMENTAL"},{"label":"Group 2","type":"EXPERIMENTAL"},{"label":"Group 3","type":"PLACEBO_COMPARATOR"}],"summary":"This study will assess the efficacy and safety of secukinumab in patients with active psoriatic arthritis who are intolerant to or have had an inadequate response to NSAIDs, DMARDs and / or TNFÎ± inhibitor therapy.","primaryOutcome":{"measure":"Percent of Patients Achieving ACR20 Response Criteria on Secukinumab 75 or 150 mg vs. Placebo","timeFrame":"Week 24","effectByArm":[{"arm":"Group 1","deltaMin":50.5,"sd":null},{"arm":"Group 2","deltaMin":50,"sd":null},{"arm":"Group 3","deltaMin":17.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":110,"countries":["United States","Argentina","Australia","Belgium","Brazil","Bulgaria","Canada","Czechia","Germany","Israel","Italy","Philippines","Poland","Romania","Russia","Singapore","Slovakia","Thailand","United Kingdom"]},"refs":{"pmids":["31943974","31203228","27696786","27169431","26422723"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":32,"n":292},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Headache","Back pain","Diarrhoea"]}}